Product Platforms


T +31 20 444 2254

Subscribe to newsletters



Translational medicine is the transformation of laboratory research outcomes into new ways to diagnose and treat patients to improve the health of millions of people worldwide. It takes promising biomedical innovations 'from bench to bedside' and bridges clinical needs from bedside to bench.

EATRIS provides a new development pathway, open to researchers and companies in need of support for advancing biomedical innovations. EATRIS comprises over 70 leading academic institutions across Europe, each renowned for its individual and high-end research facilities.

This infrastructure provides the following advantages:

  • Single point of access to the right expertise and facilities
  • Expedites the development process
  • Access to large and diverse clinical patient cohorts


BIO Convention USA

EATRIS Attends 2015 BIO USA Conference

BIO USA is considered amongst the world’s largest biotech meetings, offering opportunities for partnering and networking alongside exhibitions and professional development sessions.

H2020 Projects

Gearing Up For Two New H2020 Projects

Over the next four years, EATRIS will be involved in two Horizon 2020 projects: Coordinated Research Infrastructures Building Enduring Life-Science Services: (CORBEL) and Research Infrastructures Training Programme (RI-TRAIN).

EMA News

The European Medicines Agency (EMA) has adopted a landmark policy to take effect on 1 January 2015 ... read more




Sept 14-15

Intro Course on Regulatory Issues in ATMP Development,
Rome, Italy

Oct 7-9, 2015

ECBS & ICBS Joint Meeting 2015: "Bringing Chemistry to Life,
Berlin, Germany"